NASDAQ: AUTL
Autolus Therapeutics PLC Stock Ownership - Who owns Autolus Therapeutics?

Insider buying vs selling

Have Autolus Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cintia PiccinaCCO2026-09-026,713$2.34
$15.68kSell
Cintia PiccinaCCO2026-09-0120,000$2.35
$47.00kBuy

1 of 1

AUTL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AUTL insiders and whales buy or sell their stock.

AUTL Shareholders

What type of owners hold Autolus Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christian Itin0.42%1,116,009$2.19MInsider
Christopher Andrew Vann0.06%152,211$298.33kInsider
John E. Berriman0.05%136,331$267.21kInsider
Mak Capital One LLC0.01%33,621$65.90kInstitution
Makone0.01%33,621$65.90kInstitution
Blacks0.01%20,486$40.15kInstitution
Blackstone Inc0.01%20,486$40.15kInstitution
Synpor0.01%16,641$32.62kInstitution
Syncona Portfolio Ltd0.01%16,641$32.62kInstitution
Armistice Capital LLC0.01%15,000$29.40kInstitution

1 of 3

AUTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AUTL0.05%0.54%Net BuyingNet Buying
ARTV0.08%37.89%Net BuyingNet Buying
ZURA0.08%58.81%Net Buying
IRD0.02%99.98%Net SellingNet Buying
ENTX0.01%4.95%Net Buying

Autolus Therapeutics Stock Ownership FAQ

Who owns Autolus Therapeutics?

Autolus Therapeutics (NASDAQ: AUTL) is owned by 0.05% institutional shareholders, 0.54% Autolus Therapeutics insiders, and 99.41% retail investors. Christian Itin is the largest individual Autolus Therapeutics shareholder, owning 1.12M shares representing 0.42% of the company. Christian Itin's Autolus Therapeutics shares are currently valued at $2.10M.

If you're new to stock investing, here's how to buy Autolus Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.